Another study just published regarding use of CSL112. It shows that it is probably OK to take CSL112 when also taking Statins, which one would expect to be a common situation.
https://pubmed.ncbi.nlm.nih.gov/33932462/
"These data support concomitant use of CSL112 with alirocumab and/or atorvastatin with no anticipated negative impact on liver safety and TK."
So looks like lots of pieces of data coming together for the eventual release of the drug.
- Forums
- ASX - By Stock
- CSL
- building the case for csl112
building the case for csl112, page-8
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$275.80 |
Change
0.410(0.15%) |
Mkt cap ! $133.2B |
Open | High | Low | Value | Volume |
$276.00 | $277.50 | $274.44 | $131.0M | 472.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 83 | $275.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$275.93 | 109 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 275.600 |
1 | 47 | 275.450 |
1 | 2 | 275.370 |
1 | 100 | 275.300 |
2 | 128 | 275.000 |
Price($) | Vol. | No. |
---|---|---|
276.000 | 160 | 1 |
276.920 | 130 | 1 |
277.000 | 30 | 2 |
277.500 | 108 | 1 |
277.870 | 86 | 1 |
Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
Last
$276.25 |
  |
Change
0.410 ( 0.14 %) |
|||
Open | High | Low | Volume | ||
$276.01 | $277.50 | $274.48 | 149758 | ||
Last updated 15.59pm 03/05/2024 ? |
Featured News
CSL (ASX) Chart |